Arazlo FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 15, 2020.
Arazlo (tazarotene) is a lotion formulation of the approved retinoid tazarotene for the topical treatment of acne vulgaris in patients 9 years of age and older.
Development timeline for Arazlo
|Dec 19, 2019||Approval FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.